Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects

BACKGROUND: Lowering cholesterol levels decreases the risk of atherosclerotic diseases. Effective ways to stably reduce LDL-C level are warranted in type 2 diabetic patients, a high-risk population for CVD, with various anti-diabetic therapeutic background. The RESEARCH study focuses on LDL-C reduct...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lipids Health Dis
Main Authors: Sakamoto, Kentaro, Kawamura, Mitsunobu, Watanabe, Takayuki, Ashidate, Keiko, Kohro, Takahide, Tanaka, Akira, Mori, Yasumichi, Tagami, Motoki, Hirano, Tsutomu, Yamazaki, Tsutomu, Shiba, Teruo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5483302/
https://ncbi.nlm.nih.gov/pubmed/28646901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-017-0508-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados